Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent progress his Department has made on the rollout of Naloxone supply network coordinators.

Naloxone is a lifesaving medicine that reverses the effects of an opioid overdose, including for highly potent synthetic opioids which are growing in prevalence in the United Kingdom. It is more important than ever to increase access to naloxone products, which will save lives.

The Department recently amended the Human Medicines Regulations 2012 to further expand access to naloxone. The legislation will mean more services and professionals are able to supply this medication, which in turn means easier access to it for people at risk, and for their loved ones. This legislation came into force in early December 2024.

Route one of the legislation increased the number of services and professionals specified in regulations who can provide ‘take home naloxone’. However, not all services and professions have an agreed statutory definition across the four nations of the UK. As such, route two of the legislation set up the legal framework, which includes supply network coordinators, for the creation of a registration service for services and professions who fall outside of the definitions listed in route one to apply and to be able to provide take home naloxone. The Government is continuing to work with the devolved administrations and front-line services to explore the set-up and delivery of this registration service and to help deliver wider access to naloxone for all who need it.

The Department has also recently published the guidance, Supplying take home naloxone without a prescription, that sets out essential practical information such as who can supply naloxone, the products available, how to use naloxone and other basic lifesaving tools, and the training required. The guidance is available at the following link:

https://www.gov.uk/guidance/supplying-take-home-naloxone-without-a-prescription